Release Summary

Akaal Pharma's oral drug candidate AKP-11 Shows Superior Safety and Comparable Efficacy as compared to the Multiple Sclerosis Drug Gilenya (Fingolimod, FTY-720).

Akaal Pharma Pty Ltd